These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27483393)

  • 1. Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study.
    Pihlstrøm HK; Mjøen G; Mucha S; Haraldsen G; Franke A; Jardine A; Fellström B; Holdaas H; Melum E
    Am J Transplant; 2017 Feb; 17(2):528-533. PubMed ID: 27483393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients.
    Pihlstrøm HK; Mjøen G; Mucha S; Franke A; Jardine A; Fellström B; Dahle DO; Holdaas H; Melum E
    Am J Transplant; 2019 May; 19(5):1444-1451. PubMed ID: 30457209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the IL17A and IL17F gene polymorphisms on the long-term kidney allograft function and return to dialysis after kidney transplantation.
    Romanowski M; Kłoda K; Osękowska B; Domański L; Pawlik A; Safranow K; Ciechanowski K
    Clin Transplant; 2015 Dec; 29(12):1187-94. PubMed ID: 26447633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen.
    Woillard JB; Gatault P; Picard N; Arnion H; Anglicheau D; Marquet P
    Am J Transplant; 2018 Dec; 18(12):2905-2913. PubMed ID: 29689130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome-wide association study of recipient genotype and medium-term kidney allograft function.
    O'Brien RP; Phelan PJ; Conroy J; O'Kelly P; Green A; Keogan M; O'Neill D; Jennings S; Traynor C; Casey J; McCormack M; Conroy R; Chubb A; Ennis S; Shields DC; Cavalleri GL; Conlon PJ
    Clin Transplant; 2013; 27(3):379-87. PubMed ID: 23432519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
    Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
    Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary Approach to Stop Hypertension (DASH) diet and risk of renal function decline and all-cause mortality in renal transplant recipients.
    Osté MCJ; Gomes-Neto AW; Corpeleijn E; Gans ROB; de Borst MH; van den Berg E; Soedamah-Muthu SS; Kromhout D; Navis GJ; Bakker SJL
    Am J Transplant; 2018 Oct; 18(10):2523-2533. PubMed ID: 29464830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Association Study of Acute Renal Graft Rejection.
    Ghisdal L; Baron C; Lebranchu Y; Viklický O; Konarikova A; Naesens M; Kuypers D; Dinic M; Alamartine E; Touchard G; Antoine T; Essig M; Rerolle JP; Merville P; Taupin JL; Le Meur Y; Grall-Jezequel A; Glowacki F; Noël C; Legendre C; Anglicheau D; Broeders N; Coppieters W; Docampo E; Georges M; Ajarchouh Z; Massart A; Racapé J; Abramowicz D; Abramowicz M
    Am J Transplant; 2017 Jan; 17(1):201-209. PubMed ID: 27272414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation in the setting of chronic allograft dysfunction post-kidney transplant: phenotype and genotype.
    Israni AK; Leduc R; Jacobson PA; Wildebush W; Guan W; Schladt D; Matas AJ; Oetting WS;
    Clin Transplant; 2013; 27(3):348-58. PubMed ID: 23350966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of serum bilirubin levels on kidney transplant outcomes.
    Lee J; Kim EJ; Lee JG; Kim BS; Huh KH; Kim MS; Kim SI; Kim YS; Joo DJ
    Sci Rep; 2021 Mar; 11(1):6889. PubMed ID: 33767325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
    Drechsler C; Pihlstrøm H; Meinitzer A; Pilz S; Tomaschitz A; Abedini S; Fellstrom B; Jardine AG; Wanner C; März W; Holdaas H
    Transplantation; 2015 Jul; 99(7):1470-6. PubMed ID: 25675199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical importance of the updated Oxford classification in allograft IgA nephropathy.
    Park S; Go H; Baek CH; Kim YH; Kim YC; Yang SH; Lee JP; Min SI; Ha J; Song EY; Kim YS; Park SK; Lee H; Moon KC
    Am J Transplant; 2019 Oct; 19(10):2855-2864. PubMed ID: 31017369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of the DeKAF cross-sectional cohort study.
    Matas AJ; Fieberg A; Mannon RB; Leduc R; Grande J; Kasiske BL; Cecka M; Gaston R; Hunsicker L; Connett J; Cosio F; Gourishankar S; Rush D
    Am J Transplant; 2019 May; 19(5):1432-1443. PubMed ID: 30506642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged Ischemic Time, Delayed Graft Function, and Graft and Patient Outcomes in Live Donor Kidney Transplant Recipients.
    Krishnan AR; Wong G; Chapman JR; Coates PT; Russ GR; Pleass H; Russell C; He B; Lim WH
    Am J Transplant; 2016 Sep; 16(9):2714-23. PubMed ID: 27037866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles.
    Oetting WS; Schladt DP; Guan W; Miller MB; Remmel RP; Dorr C; Sanghavi K; Mannon RB; Herrera B; Matas AJ; Salomon DR; Kwok PY; Keating BJ; Israni AK; Jacobson PA;
    Am J Transplant; 2016 Feb; 16(2):574-82. PubMed ID: 26485092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes.
    Zhang Z; Sun Z; Fu J; Lin Q; Banu K; Chauhan K; Planoutene M; Wei C; Salem F; Yi Z; Liu R; Cravedi P; Cheng H; Hao K; O'Connell PJ; Ishibe S; Zhang W; Coca SG; Gibson IW; Colvin RB; He JC; Heeger PS; Murphy B; Menon MC
    J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34499625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.
    Knoll GA; Fergusson D; Chassé M; Hebert P; Wells G; Tibbles LA; Treleaven D; Holland D; White C; Muirhead N; Cantarovich M; Paquet M; Kiberd B; Gourishankar S; Shapiro J; Prasad R; Cole E; Pilmore H; Cronin V; Hogan D; Ramsay T; Gill J
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):318-26. PubMed ID: 26608067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial.
    Foster MC; Weiner DE; Bostom AG; Carpenter MA; Inker LA; Jarolim P; Joseph AA; Kusek JW; Pesavento T; Pfeffer MA; Rao M; Solomon SD; Levey AS
    Am J Transplant; 2017 Sep; 17(9):2390-2399. PubMed ID: 28257169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplant graft outcomes in 379 257 recipients on 3 continents.
    Merion RM; Goodrich NP; Johnson RJ; McDonald SP; Russ GR; Gillespie BW; Collett D
    Am J Transplant; 2018 Aug; 18(8):1914-1923. PubMed ID: 29573328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between TLR2, TLR4, and CD14 Gene Polymorphisms and Acute Rejection in Kidney Transplant.
    Abdolvahabi R; Sarrafnejad A; Nafar M; Jafari D; Razaghi E; Lessan-Pezashki M; Yekaninejad MS; Sharif-Paghaleh E; Amirzargar A
    Exp Clin Transplant; 2018 Feb; 16(1):31-37. PubMed ID: 28411360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.